Colon Cancer
Colon cancer survival could be extended with physical activity
Published in Cancer Weekly, October 3rd, 2006
According to recent research from the United States, "Regular physical activity reduces the risk of developing colon cancer, however, its influence on patients with established disease is unknown. We conducted a prospective observational study of 832 patients with stage III colon cancer enrolled in a randomized adjuvant chemotherapy trial. Patients reported on various recreational physical activities approximately 6 months after completion of therapy and were observed for recurrence or death."
"To minimize bias by occult recurrence, we excluded patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-10-03)
More Articles from Cancer Weekly
- Complementary & Alternative Medicine
Triptolide displayed potent antileukemic activity - Head & Neck Cancer
Head and neck carcinoma staging only slightly improved with addition of PET to CT and MR scanning - Leukemia
Leukemia risk in children with Down syndrome linked to household chemical exposure - Pediatric Radiology
Pediatricians' awareness of radiation protection issues was low - Adenoid Cystic Cancer
Sex cord tumor with annular tubules diagnosed by fine needle aspiration - Adipogenesis
Increased triplet repeat-binding protein predisposes to impaired adipogenesis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
